These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17641611)

  • 41. [Medicamentous and surgical vasodilatation in arteriosclerosis obliterans of the lower extremity].
    STEFANICS J; PAPP S; GORGO P; RANKY L
    Zentralbl Chir; 1956; 81(4):151-63. PubMed ID: 13312575
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
    Marci M; Albiani B; Ricci M; Russo F
    Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
    Scaffidi V
    Minerva Med; 1975 Jan; 66(2):55-65. PubMed ID: 1113917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Alprostan for management of critical lower limb ischemia].
    Pokrovskiĭ AV; Dan VN; Chupin AV; Kalinin AA
    Angiol Sosud Khir; 2005; 11(1):7-10. PubMed ID: 16034317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combined treatment of aged patients with obliterative atherosclerosis of legs grade IV by intraarterial infusions and CO2-laser].
    Galimzianov FV; Belova AD
    Khirurgiia (Mosk); 1998; (12):18-21. PubMed ID: 9916427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effectiveness of pathogenetic treatment of arterial obliterative diseases of the extremities].
    Belokurov IuN; Rudnev NE
    Khirurgiia (Mosk); 1993 Feb; (2):15-8. PubMed ID: 8084143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic effect of cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans.
    Yasuda K; Sakuma M; Tanabe T
    Arzneimittelforschung; 1985; 35(7A):1198-200. PubMed ID: 4074434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of chronic atherosclerotic obliterative arteriopathy in the II and IV Fontaine stage. Personal observations using iloprost].
    Marci M; Raffa S; Panzini E; Russo F
    Clin Ter; 1994 Dec; 145(12):469-74. PubMed ID: 7536648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R; Pedroni G; Borri P
    Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract]   [Full Text] [Related]  

  • 50. [Medical treatment of arteriosclerosis obliterans (ASO)].
    Matsuo H
    Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):520-5. PubMed ID: 8808815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of drug therapy for chronic obliterating diseases of lower-limb arteries on the state of the microcirculatory bed].
    Uchkin IG; Zudin AM; Bagdasarian AG; Fedorovich AA
    Angiol Sosud Khir; 2014; 20(2):27-36. PubMed ID: 24961324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Vasaprostan in everyday practice of vascular surgery department].
    Kokhan EP; Pinchuk OV; Batrashov VA
    Angiol Sosud Khir; 2003; 9(4):127-30. PubMed ID: 14657924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Critical ischemia resulted from inadequate outpatient management of lower limb chronic arterial obliterations].
    Savel'ev VS; Koshkin VM; Kunizhev AS
    Angiol Sosud Khir; 2004; 10(1):7-10. PubMed ID: 15163983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Angioprotective activity of mexicor in atherosclerosis obliterans of the lower limbs].
    Inchina VI; Smirnov LD; Romanov MD; Kokoreva EV; Morozov MIu
    Angiol Sosud Khir; 2007; 13(3):17-20. PubMed ID: 18382390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinico-instrumental evaluation of 9 cases of chronic obliterative arteriopathy of the legs treated by chemical sympathectomy].
    Gallo E; Stanzani M; Ramella G; Landi G; Machetti M; Craveri A
    Minerva Cardioangiol; 1988; 36(1-2):37-42. PubMed ID: 3386852
    [No Abstract]   [Full Text] [Related]  

  • 56. [Muscular blood flow in occlusive diseases of arteries of the lower limbs and the effect of medicinal preparations].
    Lyskova MN; Kuz'min VP; Tsypliaev VA; Bogoliubov VM
    Klin Med (Mosk); 1975 Apr; 53(4):47-50. PubMed ID: 1152370
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical aspects of using extremely high frequency electromagnetic radiation in the complex treatment of occlusive vascular diseases of the lower extremities].
    Piasetskiĭ VI; Bakharev AM; Driuk NF; Pisanko OA
    Klin Khir (1962); 1991; (7):47-50. PubMed ID: 1942833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Use of gravity therapy and discrete plasmapheresis in treatment of atherosclerosis obliterans].
    Lukashova AV; Makarov IV; Lopukhov ES
    Angiol Sosud Khir; 2014; 20(4):49-53. PubMed ID: 25490357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The results of the drug therapy of the ischemic syndrome in arteriosclerosis obliterans].
    Prokhorov GG; Potapov VV; Ogneva NS; Zybina NN
    Vestn Khir Im I I Grek; 1994; 152(1-2):30-4. PubMed ID: 7701736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. pCMV-vegf165 Intramuscular Gene Transfer is an Effective Method of Treatment for Patients With Chronic Lower Limb Ischemia.
    Deev RV; Bozo IY; Mzhavanadze ND; Voronov DA; Gavrilenko AV; Chervyakov YV; Staroverov IN; Kalinin RE; Shvalb PG; Isaev AA
    J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):473-82. PubMed ID: 25770117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.